FAQ

extensive stage small cell lung cancer

Known as: lung cancer, extensive stage small cell, Small Cell Lung Cancer, Extensive Stage, Extensive Stage Small Cell Lung Carcinoma 
Small cell lung carcinoma which has spread beyond one hemi-thorax and the regional lymph nodes.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2017
0102019802017

Related topics

Related topics

21 relations
BronchiChestEndocrine systemEpithelial Cells
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
extensive stage small cell lung cancer
cancer cell
Chest
Respiratory System
Epithelial Cells
Bronchi

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
Myeloid-derived suppressor cells (MDSC) are one of the major factors limiting the efficacy of immune therapy. In a clinical trial… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer.
BACKGROUND AND PURPOSE To define the rate of development of symptomatic chest failures in extensive stage small cell lung cancer… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2011
2011
Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer.
PURPOSE We conducted a phase II study of combination chemotherapy with irinotecan (CPT-11) and nedaplatin (NDP), (INP regimen… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2011
2011
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.
BACKGROUND AT-101 is an oral inhibitor of the antiapoptotic Bcl proteins (Bcl-2, Bcl-XL, Bcl-W, and Mcl-1) and an inducer of the… (More)
Is this relevant?
2011
2011
Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis.
BACKGROUND The authors conducted a retrospective study to evaluate the effects of thoracic radiation therapy (TRT) for patients… (More)
Is this relevant?
2009
2009
Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer.
We performed a phase II trial to test whether a cyclooxygenase (COX-2) inhibitor, celecoxib, added to standard first-line… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
PURPOSE The initial goal of this study was to test the immunologic and clinical effects of a new cancer vaccine consisting of… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).
BACKGROUND In preclinical models, the proteasome inhibitor bortezomib (PS-341) inhibits the growth of small cell lung cancer… (More)
Is this relevant?
1999
1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
PURPOSE This phase II multi-institutional trial of the Southwest Oncology Group was designed to evaluate the efficacy and… (More)
Is this relevant?
1990
1990
Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial.
We devised a novel clinical protocol for extensive-stage small cell lung cancer (SCLC), selecting chemotherapy whenever possible… (More)
Is this relevant?